Bayer AG





Market Closed - Xetra 11:38:46 2024-06-13 am EDT After market 04:00:00 pm
27.34 EUR -1.73% Intraday chart for Bayer AG 27.43 +0.30%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Archer-Daniels-Midland, Bayer to Expand Regenerative Agriculture Program to Eastern Europe MT
Dpa-AFX Overview: COMPANIES as of 11/06/2024 - 15:15 DP
Bayer: decision in China for lung cancer CF
Bayer's Lung Cancer Drug Gets Breakthrough Therapy Status in China DJ
Bayer: working with PAPACKS on sustainable packaging CF
BAYER AG : DZ Bank maintains a Buy rating ZD
WDH/Correction/Bayer must pay significantly less in glyphosate case DP
Bayer must pay significantly less in glyphosate case DP
Global markets live: Inditex, Intel, TSMC, Dollar Tree, AbbVie... Our Logo
Trending : Bayer-Owned Monsanto's Roundup Case Payment Cut to $400 Million DJ
Dpa-AFX Overview: COMPANIES from 05.06.2024 - 15:15 DP
Collective bargaining partners in the chemical industry adjourn again DP
Goldman rates Bayer at 'Neutral' - Target 31 euros DP
Reduced penalty for Bayer inspires investors only briefly DP
BAYER AG : Goldman Sachs remains Neutral ZD
Reduced fine drives Bayer - but only slight relief DP
US Judge Lowers Bayer's Payment for Guilty Verdict in Cancer Case Linked to Roundup Weedkiller MT
Judge cuts Bayer $2.25 billion Roundup verdict to $400 million RE
Monsanto's Weedkiller Payout Slashed to $400 Million From $2.25 Billion DJ
Bayer: strategic collaboration with Samsung for SDM CF
German Shares Edge Up as Eurozone Sentiment Data Improves MT
Burning Rock Biotech to Work With Bayer to Increase Patient Access to Precision Cancer Medicines in China MT
Bayer Wins US FDA's Regenerative Medicine Advanced Therapy Tag for Parkinson's Disease Drug MT
Bayer: 'RMAT' designation obtained in the USA for Parkinson's disease CF
Bayer and Burning Rock Biotech Limited Collaborates to Increase Patient Access to Precision Cancer Medicines CI
Chart Bayer AG
More charts
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
27.82 EUR
Average target price
36.18 EUR
Spread / Average Target
  1. Stock Market
  2. Equities
  3. BAYN Stock
  4. News Bayer AG
  5. IQ-AI Unit Delivers Software to Insel Gruppe